Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca New programs added in Respiratory and Cardio-Metabolic Diseases CAMBRIDGE, U.K., and BOSTON, Mass., MAY 24, 2018 — Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that it is expanding its collaboration with AstraZeneca to … Continue reading Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca